A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with ...

A research team from University College London (UCL) in the UK announced on the 24th of last month, local time, that they ...

Dr Lee Coffey’s research at SETU on gene therapies for a rare neurological disease was inspired by family circumstances.

The phosphoramidites market shows promising growth in oligonucleotide synthesis, key to gene therapy and personalized ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

University of Bristol biotech spin-out company Cirrus Therapeutics has today (Thursday 2 October) announced the close of an ...

UC Davis Health researchers are testing a new gene therapy that could be transformational for patients with Angelman syndrome ...

Key market opportunities in the global cell biology research market include advances in instrumentation, consumables, and software driven by data-driven models. There's potential in enhanced ...

The U.S. cell & gene therapy CRO market offers opportunities in advanced therapies, strategic outsourcing, and regulatory navigation. Demand is driven by biotech firms outsourcing due to lacking ...